TPWA
CRL icon

TRUE Private Wealth Advisors’s Charles River Laboratories CRL Stock Holding History

TRUE Private Wealth Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24
Closed -$3.23K – 376
2018
Q3 		$3.23K Buy
+24
New +$2.96K ﹤0.01% 963

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

TRUE Private Wealth Advisors's CRL Position: Q4 2018 in Review

TRUE Private Wealth Advisors sold out of Charles River Laboratories (CRL) in Q4 2018, closing a stake of 24 shares — an estimated $3.23K sold.

TRUE Private Wealth Advisors first reported a position in CRL in Q3 2018 and held it in 1 quarter. The position peaked at $3.23K in Q3 2018. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

  • TRUE Private Wealth Advisors reported no remaining Charles River Laboratories position as of Q4 2018 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 24 Charles River Laboratories shares in Q4 2018, an estimated $3.23K.
  • TRUE Private Wealth Advisors first reported a position in Charles River Laboratories in Q3 2018 and held it in 1 quarter.
  • TRUE Private Wealth Advisors's Charles River Laboratories position peaked at $3.23K in Q3 2018.
  • 407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on TRUE Private Wealth Advisors's 13F filing for Q4 2018, filed 14 Jan 2019.